1. Treatment
Early and timely wide local resection of the scrotum is the preferred treatment, and the resection range should extend 2 cm beyond the normal skin around the visible tumor lesions on the scrotum wall, including the epidermis, dermis, up to the tunica albuginea of the tunica vaginalis of the testis. If the deep tissue is involved, the testis and spermatic cord should be resected together. If the resection range is too large, a local flap reconstruction or scrotal reconstruction can be performed (Payne, 1994). Recently, there have been reports that in order to completely resect the lesion, intraoperative frozen biopsy or intraoperative rapid carcinoembryonic antigen staining can be used to determine the resection range (Harris, 1994).
Enlarged lymph nodes in the inguinal area are often caused by inflammation and may not be metastasis, so prophylactic lymph node dissection is not necessary. As with the treatment of penile cancer, anti-infection treatment should be initiated at the beginning of treatment, and if the lymph node biopsy is negative after the lesion is resected, continue anti-infection treatment. If there is still suspicion, re-biopsy, and only if the biopsy is positive, perform lymph node dissection, and at the same time, remove the ipsilateral testis and spermatic cord. The operation should be performed 2-3 weeks after the primary lesion is resected to reduce the occurrence of incisional infection, flap necrosis, and lymph fistula.
Radiation and chemotherapy are not sensitive to scrotal inflammatory carcinoma, so the use of radiation and chemotherapy alone, as well as the use of bleomycin and fluorouracil locally, is not effective. However, since the tumor infiltration is deep and the resection is not thorough, adjuvant use before and after surgery can enhance efficacy, reduce recurrence, and control metastasis (Inamura, 1999). There are also reports that the combination of cyclophosphamide, daunorubicin, cisplatin, and methotrexate (aminopterin) chemotherapy plus radiotherapy has achieved certain effects in palliative or concurrent adenocarcinoma in the late stage (Shinura, 1994).
2. Prognosis
The efficacy of treatment largely depends on whether the dermis is involved. Early lesions are limited to the epidermis and appendages, and if the surgery is thorough, the prognosis is good. If the lesions involve the dermis, even if regional lymph nodes have been invaded, the prognosis is poor, and the postoperative survival time rarely exceeds 5 years.